Venture Capital Group Amends Stake in Hims & Hers

TL;DR

VC group IVP XV/XVI filed 13D/A on HIMS, changing ownership details.

AI Summary

Institutional Venture Management XVI, LLC and its affiliates have filed an amendment to their Schedule 13D concerning Hims & Hers Health, Inc. The filing, dated May 22, 2024, indicates a change in beneficial ownership. The group previously operated under the name Oaktree Acquisition Corp. before changing it on April 12, 2019.

Why It Matters

This filing signals a potential shift in the ownership structure or strategy of Hims & Hers Health, Inc., which could impact its stock performance and future business decisions.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings can indicate shifts in investor sentiment or strategy, potentially affecting the stock price.

Key Players & Entities

• Institutional Venture Management XVI, LLC (company) — Filing entity
• Hims & Hers Health, Inc. (company) — Subject company
• Oaktree Acquisition Corp. (company) — Former company name
• DENNIS B. PHELPS (person) — Group member
• ERIC LIAW (person) — Group member
• J. SANFORD MILLER (person) — Group member
• JULES A. MALTZ (person) — Group member
• NORMAN A. FOGELSONG (person) — Group member
• SOMESH DASH (person) — Group member
• STEPHEN J. HARRICK (person) — Group member

FAQ

Key Financial Figures

• $0.0001 — suer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• tm2415368d1_sc13da.htm (SC 13D/A) — 271KB
• 0001104659-24-064378.txt ( ) — 273KB

From the Filing

SC 13D/A 1 tm2415368d1_sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Hims & Hers Health, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 433000 106 (CUSIP Number) Tracy Hogan Institutional Venture Partners 3000 Sand Hill Road Building 2, Suite 250 Menlo Park, California 94025 (650) 854-0132 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) May 20, 2024 (Date of Event Which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 433000 106 Schedule 13D Page 2 of 18 Pages (1) Names of reporting persons Institutional Venture Management XV, LLC (2) Check the appropriate box if a member of a group (see instructions) (a) (b) (3) SEC use only (4) Source of funds (see instructions): AF (5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e) (6) Citizenship or place or organization Delaware Number of shares beneficially owned by each reporting person with: (7) Sole voting power: 0 (8) Shared voting power: 2,597,558 (1) (9) Sole dispositive power: 0 (10) Shared dispositive power: 2,597,558 (1) (11) Aggregate amount beneficially owned by each reporting person: 2,597,558 (1) (12) Check if the aggregate amount in Row (11) excludes certain shares (see instructions) (13) Percent of class represented by amount in Row (11): 1.3% (2) (14) Type of reporting person (see instructions): OO (1) Consists of: (i) 2,571,116 shares of Class A Common Stock held directly by Institutional Venture Partners XV, L.P. (“IVP XV”); (ii) 13,613 shares of Class A Common Stock held directly by Institutional Venture Partners XV Executive Fund, L.P. (“IVP XV EF”); and (iii) 12,829 shares of Class A Common Stock held directly by Institutional Venture Management XV, LLC (“IVM XV”). IVM XV is the general partner of IVP XV and IVP XV EF and may be deemed to share voting and dispositive power over the shares held by IVP XV and IVP XV EF. (2) Calculations of the percentage of the shares of Class A Common Stock beneficially owned is based on 205,872,690 shares of Class A Common Stock outstanding as of May 3, 2024 as disclosed in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 6, 2024. Represents 1.2% of the total number of outstanding shares of common stock, including 8,377,623 shares of Class V Common Stock (which is entitled to 175 votes per share) and 0.2% of the total voting power of the Issuer. CUSIP No. 433000 106 Schedule 13D Page 3 of 18 Pages (1) Names of reporting persons Institutional Venture Partners XV, L.P. (2) Check the appropriate box if a member of a group (see instructions) (a) (b) (3) SEC use only (4) Source of funds (see instructions): WC (5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e) (6) Citizenship or place or organization Delaware Number of shares beneficially owned by each reporting person with: (7) Sole voting power: 0 (8) Shared voting power: 2,571,116 (1) (9) Sole dispositive power: 0 (10) Shared dispositive power: 2,571,116 (1) (11) Aggregate amount beneficially owned by each reporting person: 2,571,116 (1) (12) Check if the aggregate amount in Row (11) excludes certain shares (see instructions) (13) Percent of class represented by amount in Row (11): 1.2% (2) (14) Type of reporting person (see instructions): PN (1) Consists of 2,571,116 shares of Class A Common Stock held directly by IVP XV. (2) Calculations of the percentage of the shares of Class A Common Stock beneficially owned is based on 205,872,690 shares

View Full Filing

View this SC 13D/A filing on SEC EDGAR